Follow-on funding · Healthtech

Biopeak raises $2.7 million follow-on funding led by NKSquared

The clinic business plans to expand diagnostics, software and clinical programmes.

Biopeak announced a $2.7 million follow-on investment on 29 January 2026, led by NKSquared, the investment vehicle of Nikhil Kamath. The financing supports expansion of the company’s preventive-care clinic model.

The company plans to open a second clinic and invest in diagnostics, proprietary AI tools, research and clinical programmes. It also intends to recruit for its clinical, research, product and operations teams.

Founded by Rishi Pardal and Shiva Subramanian, Biopeak combines specialist consultations, diagnostic testing and ongoing monitoring. Its model brings health information and follow-up into coordinated programmes, rather than treating assessments as isolated appointments.

Use of funds

Clinic expansion

Diagnostics and software

Research and clinical teams

Funding history

Follow-on funding · This round$2.7M
SeedUndisclosed

Sources

  1. Nikhil Kamath invests $2.7million in Biopeakeconomictimes.indiatimes.com · Jan 29, 2026
  2. Biopeak latest funding press coveragebiopeak.com · Jan 29, 2026